Down below are links to RAFAEL PHARMA BAD NEWS. From April and now. Can be a big issue for us. Hole not.
The 10Q filed by TYME today is positive in tone on our shot with sarcoma. And has a lot moe technical data than we ever got from last board
I got a grudge with those boys honestly. Side stepped a lot of shit. Big shake up DID point to issues.
The DOWN TO BUSINESS style by Chnninghzm.
We had the recent 100k buy in by one insider. I need more of that for comfort. Check out the links kn RAFAEL info only. They're on hitting the glucose side we're Tyrosine.
May be a reason why we dropped our aelf-sponsored pancreatic cancer trial.
Good Luck To All of us.
Phase 3 ARMADA 2000 Trial of Devimistat in Relapsed/Refractory AML to Continue
https://www.onclive.com/view/phase-3-armada-2000-trial-of-devimistat-in-relapsed-refractory-aml-to-continue
Rafael Pharma Shares Down 75% After Pancreatic Cancer Trial Didn't Meet Primary Endpoint - MarketWatch
https://www.marketwatch.com/story/rafael-pharma-shares-down-75-after-pancreatic-cancer-trial-didn-t-meet-primary-endpoint-271635424625
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM